论文部分内容阅读
生长分化因子-15(GDF-15)系机体应激反应产物之一,并可作为判别非ST段抬高型急性冠脉综合征患者继后复发再梗死和死亡风险增加的生物指标之一。然而迄今关于对急性胸痛患者进行有效早期危险分层的相关指标既少又欠可靠。现就GDF-15在对非选择性急性胸痛患者进行早期危险分层中
Growth-differentiation factor-15 (GDF-15) is one of the products of body stress response and can be used as one of the biomarkers to determine the relapse of non-ST segment elevation acute coronary syndrome patients with recurrent infarction and increased risk of death. However, to date, the relevant indicators on effective early risk stratification in patients with acute chest pain are both less reliable and less reliable. GDF-15 is now being used in early risk stratification of patients with nonselective acute chest pain